These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3639669)

  • 1. Tumor promoter, TPA, enhances replication of HTLV-III/LAV.
    Harada S; Koyanagi Y; Nakashima H; Kobayashi N; Yamamoto N
    Virology; 1986 Oct; 154(2):249-58. PubMed ID: 3639669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
    Nakashima H; Matsui T; Harada S; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
    Antimicrob Agents Chemother; 1986 Dec; 30(6):933-7. PubMed ID: 2434024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of human immunodeficiency virus infected cells by TPA-type and non-TPA type tumor promoters.
    Harada S; Yamamoto N; Fujiki H
    AIDS Res Hum Retroviruses; 1988 Apr; 4(2):99-105. PubMed ID: 3365359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events.
    Harada S; Koyanagi Y; Yamamoto N
    Virology; 1985 Oct; 146(2):272-81. PubMed ID: 2413616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV).
    Balzarini J; Mitsuya H; De Clercq E; Broder S
    Int J Cancer; 1986 Mar; 37(3):451-7. PubMed ID: 2419266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of virus production and induction of self-syncytium formation in human T-cell leukemia virus type I- and type II-infected T cells by 12-O-tetradecanoylphorbol-13-acetate.
    Wolfson M; Lev M; Avinoah I; Malik Z; Löchelt M; Flügel RM; Dombrovski A; Aboud M
    J Virol; 1994 Jul; 68(7):4695-9. PubMed ID: 8207847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.
    Harada S; Koyanagi Y; Yamamoto N
    Science; 1985 Aug; 229(4713):563-6. PubMed ID: 2992081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
    McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
    J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
    Nicholson JK; Cross GD; Callaway CS; McDougal JS
    J Immunol; 1986 Jul; 137(1):323-9. PubMed ID: 3011909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)].
    Ito M; Nakashima H; Baba M; Pauwels R; De Clercq E; Shigeta S; Yamamoto N
    Antiviral Res; 1987 Mar; 7(3):127-37. PubMed ID: 3475037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous production of a cytopathic human T-lymphotropic virus in a permissive neoplastic T-cell line.
    Getchell JP; Heath JL; Hicks DR; Sporborg C; McGrath CR; Kalyanaraman VS
    J Clin Microbiol; 1986 Apr; 23(4):737-42. PubMed ID: 2422205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses.
    Margolick JB; Volkman DJ; Folks TM; Fauci AS
    J Immunol; 1987 Mar; 138(6):1719-23. PubMed ID: 3493285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human interferon gamma suppresses HTLV-III replication in vitro.
    Nakashima H; Yoshida T; Harada S; Yamamoto N
    Int J Cancer; 1986 Sep; 38(3):433-6. PubMed ID: 3017871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal selection of human immunodeficiency virus (HIV): serological differences in the envelope antigens of the cloned viruses and HIV prototypes (HTLV-III B, LAV, and ARV).
    Harada S; Kobayashi N; Koyanagi Y; Yamamoto N
    Virology; 1987 Jun; 158(2):447-51. PubMed ID: 2438845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substances affecting the infection and replication of human immunodeficiency virus (HIV).
    Yamamoto N; Harada S; Nakashima H
    AIDS Res; 1986 Dec; 2 Suppl 1():S183-9. PubMed ID: 3030346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection of the HTLV-II-bearing T-cell line C3 with HTLV-III/LAV is highly permissive and lytic.
    Montefiori DC; Mitchell WM
    Virology; 1986 Dec; 155(2):726-31. PubMed ID: 3024409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS.
    Gartner S; Markovits P; Markovitz DM; Betts RF; Popovic M
    JAMA; 1986 Nov; 256(17):2365-71. PubMed ID: 3490587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
    J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor promoters alter the temporal program of adenovirus replication in human cells.
    Fisher PB; Young CS; Weinstein IB; Carter TH
    Mol Cell Biol; 1981 Apr; 1(4):370-80. PubMed ID: 6965103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of cytotoxic effect of tumor necrosis factor on human immunodeficiency virus-infected cells by staurosporine, a potent protein kinase C inhibitor.
    Hamamoto Y; Matsuyama T; Yamamoto N; Kobayashi N
    Cancer Res; 1990 Sep; 50(17):5287-90. PubMed ID: 2386936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.